FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.

This publication has 10 references indexed in Scilit:

• FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics.
  The Journal of Antibiotics, 1987
• Cyclosporine therapy of rat heart allograft recipients and release of interleukins (IL 1, IL 2, IL 3): a role for IL 3 in graft tolerance?
  The Journal of Immunology, 1984
• Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets.
  The Journal of Immunology, 1983
• The role of a gamma interferon-like lymphokine in the activation of T cells for expression of interleukin 2 receptors
  Cellular Immunology, 1983
• CYCLOSPORIN-A INHIBITS LYMPHOKINE PRODUCTION BUT NOT THE RESPONSES OF MACROPHAGES TO LYMPHOKINES
  1983
• Concanavalin A triggers T lymphocytes by directly interacting with their receptors for activation.
  The Journal of Immunology, 1982
• Effect of cyclosporin A on human lymphocyte responses in vitro. II. Induction of specific alloantigen unresponsiveness mediated by a nylon wool adherent suppressor cell.
  The Journal of Immunology, 1981
• Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2
  European Journal of Immunology, 1981
• Effect of cyclosporin A on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR.
  The Journal of Immunology, 1980
• Cyclosporin A and dexamethasone suppress T cell responses by selectively acting at distinct sites of the triggering process.
  The Journal of Immunology, 1980